+
CSIR-NIIST introduces new tech for biomedical waste safety
WATER & WASTE

CSIR-NIIST introduces new tech for biomedical waste safety

The CSIR-National Institute for Interdisciplinary Science and Technology (CSIR-NIIST) had introduced a pioneering technology aimed at the safe, sustainable, and cost-effective management of biomedical waste, representing a significant milestone as the first of its kind in the country.

This groundbreaking technology had been unveiled during the Biomedical Waste Management Conclave, a one-day event held at the CSIR-NIIST campus in the city on March 26.

As reported by UNI, Dr M Srinivas, Director of AIIMS New Delhi, had inaugurated the event, which had been presided over by Dr N Kalaiselvi, Secretary of DSIR and Director General of CSIR, via videoconferencing.

Dr Srinivas had stressed the importance of innovative technologies in the biomedical sector and had reiterated AIIMS' commitment to collaborating with academic and research institutions, particularly CSIR. He had praised CSIR-NIIST Director Dr C Anandharamakrishnan and his team for their innovative solution for the disposal of pathogenic biomedical waste.

Dr Kalaiselvi had remarked that the biomedical waste treatment technology developed by CSIR-NIIST would effectively tackle one of the major challenges of modern times. She had noted, "This technology will significantly impact the global biomedical arena by addressing the limitations of conventional technologies, including energy-intensive incineration."

Dr Anandharamakrishnan had explained that with the technology, one kilogram of medical waste could be converted into soil additives in three minutes, suitable for agricultural purposes. As per the UNI news agency, he had mentioned that this safe and cost-effective technology would facilitate hospitals in disposing of medical waste easily at its source.

However, the implementation of this technology in hospitals nationwide necessitated approval from the Central Pollution Control Board.

"CSIR-NIIST is actively exploring various waste management strategies, including biomedical waste. The technology we developed for converting pathogenic biomedical waste into value-added soil additives serves as a perfect example of the 'Waste to Wealth' concept," he had added.

Following the development of this groundbreaking technology, CSIR-NIIST had transferred it to Bio Vastum Solutions, a firm based in Angamaly.

The CSIR-National Institute for Interdisciplinary Science and Technology (CSIR-NIIST) had introduced a pioneering technology aimed at the safe, sustainable, and cost-effective management of biomedical waste, representing a significant milestone as the first of its kind in the country. This groundbreaking technology had been unveiled during the Biomedical Waste Management Conclave, a one-day event held at the CSIR-NIIST campus in the city on March 26. As reported by UNI, Dr M Srinivas, Director of AIIMS New Delhi, had inaugurated the event, which had been presided over by Dr N Kalaiselvi, Secretary of DSIR and Director General of CSIR, via videoconferencing. Dr Srinivas had stressed the importance of innovative technologies in the biomedical sector and had reiterated AIIMS' commitment to collaborating with academic and research institutions, particularly CSIR. He had praised CSIR-NIIST Director Dr C Anandharamakrishnan and his team for their innovative solution for the disposal of pathogenic biomedical waste. Dr Kalaiselvi had remarked that the biomedical waste treatment technology developed by CSIR-NIIST would effectively tackle one of the major challenges of modern times. She had noted, This technology will significantly impact the global biomedical arena by addressing the limitations of conventional technologies, including energy-intensive incineration. Dr Anandharamakrishnan had explained that with the technology, one kilogram of medical waste could be converted into soil additives in three minutes, suitable for agricultural purposes. As per the UNI news agency, he had mentioned that this safe and cost-effective technology would facilitate hospitals in disposing of medical waste easily at its source. However, the implementation of this technology in hospitals nationwide necessitated approval from the Central Pollution Control Board. CSIR-NIIST is actively exploring various waste management strategies, including biomedical waste. The technology we developed for converting pathogenic biomedical waste into value-added soil additives serves as a perfect example of the 'Waste to Wealth' concept, he had added. Following the development of this groundbreaking technology, CSIR-NIIST had transferred it to Bio Vastum Solutions, a firm based in Angamaly.

Next Story
Infrastructure Transport

Lucknow Metro East-West Corridor Consultancy Contract Awarded

The Uttar Pradesh Metro Rail Corporation has awarded the first construction-related consultancy contract for the Lucknow Metro East West Corridor to a joint venture of AYESA Ingenieria Arquitectura SAU and AYESA India Pvt Ltd. The firm was declared the lowest bidder for the Detailed Design Consultant contract for Lucknow Metro Line-2 under Phase 1B and the contract was recommended following the financial bid. The contract is valued at Rs 159.0 million (mn), covering design services for the corridor. Lucknow Metro Line-2 envisages the construction of an 11.165 kilometre corridor connecting Cha..

Next Story
Infrastructure Urban

Div Com Kashmir Urges Fast Tracking Of Jhelum Water Transport Project

The Divisional Commissioner of Kashmir has called for the fast-tracking of the Jhelum water transport project, urging district administrations and relevant agencies to accelerate planning and clearances. In a meeting convened at the divisional headquarters, the commissioner instructed officials from irrigation, public health engineering and municipal departments to prioritise the project and coordinate survey and design work. The directive emphasised removal of administrative bottlenecks and close monitoring to ensure timely mobilisation of resources and contractors. Officials were told to in..

Next Story
Infrastructure Urban

Interarch Reports Strong Q3 And Nine Month Results

Interarch Building Solutions Limited reported unaudited results for the third quarter and nine months ended 31 December 2025, recording strong revenue growth driven by execution and a robust order book. Net revenue for the third quarter rose by 43.7 per cent to Rs 5.225 billion (bn), compared with Rs 3.636 bn a year earlier, reflecting heightened demand in pre-engineered building projects. The company’s total order book as at 31 January 2026 stood at Rs 16.85 bn, supporting near-term visibility. EBITDA excluding other income for the quarter increased by 43.2 per cent to Rs 503 million (mn),..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Open In App